JC 06 (Medicine) - Ischaemic heart disease, Angina pectoris Flashcards

(48 cards)

1
Q

6 pathophysiological processes that cause MI

A
  1. Critical coronary stenosis
  2. Vascular Inflammation
  3. Coagulopathies
  4. Vasospasm
  5. Microvascular dysfunction
  6. Endothelial dysfunction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Explain the pathophysiological changes in epicardial coronary arteries that lead to myocardial ischemia

A

Insufficient oxygen supply to myocardial tissue by 2 mechanisms:

  1. Atherosclerotic disease
    - Stable plaque > Reduction in CFR > Demand ischaemia +/- angina
    - Vulnerable plaque > Plaque rupture > Thrombosis > Acute coronary syndrome/ Infarction
  2. Vasospastic disease
    - Focal/ transient vasospasm > Prinzmetal angina
    - Persistent vasospasm > Myocardial infarction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Explain the pathophysiological changes in coronary microcirculation that lead to myocardial ischemia

A

Microvascular dysfunction

> impairs coronary physiology and myocardial blood flow

> myocardial ischaemia in CAD and Cardiomyopathies

> Severe acute ischaemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Mechanism of ischemic chest pain (referred pain)

A

Ischemic episodes
> excite chemosensitive and mechanosensitive receptors in heart
> Release adenosin, bradykinin, cytokines
> Excite sensory sympathetic and vagal afferent fibers
> Upper thoracic sympathetic ganglia and thoracic roots of spinal cord
> cardiac sympathetic afferents impulses converge with somatic thoracic structures
> Chest pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Mechanism of silent myocardial ischaemia

A

Long term diabetes
> Reduced nerve growth factor
> failed development of cardiac sensory system
> failed afferent signal to thoracic ganglia and impulse convergence with somatic nerve fibers
> no chest pain

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Prevalence of angina

Typical presentations

A

> 60 years old = 25-37% men and 16-23% women

50% present with angina pectoris
50% with acute coronary syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Primary cardiac causes of IHD

A
  1. Coronary artery abnormalities:
    - Spasm, arteritis, dissection, malformation, myocardail bridging
  2. Valvular
    - Aortic stenosis
  3. Structural
    - Hypertrophic cardiomyopathy, Dilated cardiomyopathy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Primary non-cardiac causes of IHD

A
  1. Decrease oxygen delivery - hypoxemia
    - Anemia, Sickle cell disease, carbon monoxide poisoning
  2. Endocrine
    - Hyperthyroidism (thyrotoxic AF), Pheochromocytoma
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Effect of LDL levels on onset of IHD

A

Reduce LDL cholesterol = delay onset of IHD

Familial hypercholesterolemia greatly decreases age of IHD onset

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Pathogenesis of atherosclerotic plaque formation

A
  1. Atherophil (modified smooth muscle cells or macrophages) proliferate
    > Atherocyte phagocytizes lipids
    > Lipid-laden atherocytes die and release lipids
    > Other atherocytes engulf lipid content under sufficient oxygen
    > Increasing platelet and fibrin blocks O2 diffusion and astrocytes cannot engulf lipid content
    > extra-cellular lipid accumulates, internal elastic membrane fractures and stiffens
    > Pathological intimal thickening
  2. Fibrophils (modified fibroblasts or histocytes) produce fibrous tissue and accelerate calcium deposition
    > Fibroatheroma formation

> > Formation of atherosclerotic plaque in intima layer

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Define risk factors of coronary artery disease

A

□ Modifiable: abdominal obesity, BP, cholesterol, cigarette smoking, alcohol, diet, DM, lack of exercise, cocaine abuse

□ Non-modifiable: family Hx of CVD, male gender, advanced age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Define stable, unstable angina

Define myocardial infarction

A

□ Stable angina: ischaemia due to fixed stenosis
□ Unstable angina: ischaemia due to dynamic obstruction (e.g. ruptured atherosclerotic plaque, acute thrombosis)
□ Myocardial infarction: myocardial necrosis due to acute occlusion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Typical presentation of stable angina (ESC Guidelines)

Provoking and relieving factors

A

Retrosternal chest discomfort with typical quality (dull, constricting) and duration (<30min)
→ ± radiation to arms, shoulder, jaw

Provoked by exertion or emotion

Relieved by rest or sublingual nitrate ≤5min

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Clinical grading of angina pectoralis

A
CCS grading of angina pectoralis
0 – asymptomatic
I – angina with strenuous exertion
II – angina with moderate exertion
(slight limitation of ordinary activities)
III – angina with mild exertion
(great limitation) → indicated for Tx
IV – angina at rest
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Patterns of pain radiation in angina pectoris

A
Neck/ throat tightness
Lower jaw 
Left shoulder or arm in ulnar distribution 
Interscapular 
Epigastrium 
Back 

Sometimes to right arm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Associated non-chest pain manifestations of myocardial ischemia

A

Dyspnea:

  • rest or exertional
  • Paroxysmal nocturnal dyspnea

Abdomen:

  • Atypical, sharp pain
  • RUQ pain (mimic pancreatitis or gallbladder disease)
  • Nausea and vomiting

Psychologial:
- Intense Fear

Diaphoresis

Weakness, syncope, coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Signs of risk factors of coronary artery disease

A
  1. BP: >15mmHg arm BP disparity
  2. > 30 BMI
  3. Lipid
    - Cutaneous xanthomas, xanthelesma, corneal arcus
  4. DM:
    - acathosis nigricans, skin tags
  5. Others:
    - Franks sing (ear lobe crease)
    - Tar stains, teeth stains
    - Wheezing, prolonged expiration (COPD)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Signs of coronary artery disease complications

A
  1. CHF:
    - Increase JVP
    - Abnormal heart sounds
    - Displaced apex
    - Low-output cardiac failure
  2. Arrhythmia
  3. PAD:
    - Peripheral pulse absence
    - Carotid bruit
    - Trophic signs
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Baseline investigations for suspected coronary artery disease (4 tests)

A

Blood tests

12-lead ECG:
- Evidence of MI, myocardial damage

Echocardiogram:

  • LVEF (prognostic)
  • Structural heart diseases
  • Regional wall motion abnormalities

CXR:
- Pulmonary cause or complications

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Outline full spread of blood test metrics for suspected coronary artery disease

A

Blood:

  • CBC
  • Thyroid function test
  • Fasting glucose, HbA1c, OGTT > DM
  • Fasting lipid profile > Hyperlipidaemia
  • RFT/ Creatinine (prognostic)
  • LFT, CK (statin)

Markers:

  • High-sensitivity C-reactive proteins
  • Brain natriuretic peptide (BNP)
  • hs- TNT
21
Q

List diagnostic investigations for suspected coronary artery disease

A

→ Anatomical test: CT coronary angiography
→ Functional test: exercise tolerance test (ETT), stress echo
→ Myocardial perfusion scintigraphy
→ Cardiac MRI

22
Q

Modalities of cardiac stress tests (3)

A

□ Exercise: bicycle ergometer, treadmill test

□ Vasodilators, eg. adenosine, dipyridamole → based on ‘coronary steal phenomenon’

□ Inotropes, eg. dobutamine

Conducted with 12-lead ECG, BP, ECHO
Positive = horizontal or down-sloping ST depression of >0.1mm
Positive ECHO = regional wall motion abnormality, LV dysfunction

23
Q

Outline the selection process of diagnostic investigations for suspected coronary artery disease

A
  1. Contraindicated for stress testing / Clinical findings warrant coronary imaging&raquo_space; CT Coronary angiography
  2. No contraindication for stress testing + unable to exercise&raquo_space; Pharmacological stress test
  3. No contraindication for stress test + able to exercise&raquo_space; Exercise stress test
  4. No contraindication for stress test + able to exercise + no previous revascularization/ resting ECG normal&raquo_space; Exercise tolerance test with ECG

2,3,4 may require follow-up coronary imaging if high risk or inadequate information for diagnosis

24
Q

Direct indications for coronary angiogram

A
  1. Unacceptable angina despite medical therapy
  2. Non-invasive test results with high-risk features
  3. Angina or risk of CAF with depressed LVEF
  4. Unclear non-invasive test results and prognosis
25
5 principles of management of IHD
Patient education and decision making Manage comorbid conditions Aggressive modification of preventable risk factors Pharmacological management Revascularization surgery: PCI, CABG
26
Lifestyle changes for management of IHD
□ Lifestyle: stop smoking, regular exercise □ Treat precipitating factors: thyrotoxicosis, anaemia □ Manage risk factors: → DM: aim HbA1c <7%, consider SGLT2i or GLP-1a → HTN: aim <140/90, use BB if indicated → Lipids: ↓LDL to <1.8mmol/L with lifestyle and drug
27
CVD prevention in patients with diagnosed atherosclerotic cardiovascular disease (4)
LDL-C >50% reduction and <1.8mmol/L SBP <140 - 130 mmHg Antithrombotic therapy Stop smoking and lifestyle recommendations
28
Outline 6 classes of lipid modifying therapies proven to reduce CVD
Statins (1st line) Cholesterol absorption inhibitors e.g. Ezetimibe (2nd line) PCSK9 inhibitors (3rd line) Bile acid sequestrants Long-chain omega-3 fatty acids antisense oligonucleotide inhibitor of apolipoprotein B (for familial hypercholesterolemia ONLY)
29
Which lipid modifying therapy is most effective in lowering LDL-C and non-HDL-C?
PCSK9 inhibitors
30
List classes of drugs for prognostic improvement of IHD
1. Antiplatelets/ anticoagulants 2. Statins/ lipid modifying drugs: in all patients regardless of LDL, first line 3. ± ACEI only in those with HTN, LVEF ≤40%, DM/CKD 4. ± ARB only in those with SIHD, HTN, DM, Poor LVEF and refractory to ACEI
31
List specific antiplatelet/ anticoagulant combinations for prognostic improvement of IHD
1. Aspirin (1st line) 2. Clopidogrel (2nd line, refractory/ CO to aspirin, post MI) 3. Aspirin + P2Y12 blocker (Ticagrelor/ Prasugrel): after PCI/ Mutli-vessel CAD/ Post-MI 4. Aspirin + Rivaroxaban: High risk CAD/ PAD, Post-MI
32
List specific drugs for angina relief (standard first line treatment)
Symptomatic → relieve ischaemia during angina episodes □ 1st-line: Urgent: PRN sublingual nitrates Long-term: Long-acting nitrates + Beta-blocker or CCB/ Beta-blocker + DHP- CCB if severe □ 2nd-line: long-acting nitrates, ivabradine, trimetazidine, ranolazine, nicorandil
33
Contraindications for ACEI/ ARB use in IHD patients
Bilateral renal artery stenosis
34
Indications for CABG over PCI
Two vessel disease and proximal LAD lesion Triple vessel disease Unprotected left main coronary artery disease
35
Indication for B-blocker use in IHD
- First-line monotherapy or combination with CCB or nitrate to decrease angina - Systolic LV failure (LVEF < 40%) and past-MI - Ventricular rate control in A-fib
36
Side effects and contraindications of B-blocker use in IHD
Side effects: - Bradycardia, syncope, hypotension, bronchial spasm Contraindications: (electrical and veqssel problems) - AV block, sinus node dysfunction - Bronchial asthma (vasocontriction) - Vasospasm angina, PAD, Raynaud's phenomenon - Depression
37
Indication for CCB use in IHD
Monotherapy if refractory/ intolerant to B-blocker Combination with B-blocker or nitrates to decrease angina Vasospasm angina ** (B-blocker C/O) Ventricular rate control in A-fib
38
Side effects and contraindications of CCBs
Side effects: Bradycardia (non-DHP CCBs) syncope, hypotension, peripheral edema, headache, dizziness, constipation C/O: AV block, Heart failure, sinus node dysfunction
39
Differences and similarities between Amlodipine, Nifedipine, Diltiazem and Verapamil action on heart (different CCBs)
Amlodipine and Nifedipine: (for low basal HR) - Increase HR - No effects on SA and AV node conduction Diltiazem and Verapamil: (for tachycardia) - Decrease HR - Decrease SA and AV node conduction ALL: - Decrease myocardial contractility - Increase neurohormonal activation - Increase vascular dilation - Increase coronary flow
40
Indications of nitrate use for IHD
Releive acute anginal pain Prophylaxis to increase exercise tolerance and prevent exercise-induced ischaemia Long-acting nitrate to decrease angina
41
Side effects and C/O of nitrate use in IHD
Side effects: - Hypotension, syncope, tachycardia, headache C/O: - HOCM - Same-day use with Selective Phosphodiesterase Inhibitors (PDE-5) e.g. Sildenafil - SBP <90mmHg/ Severe hypotension
42
List 4 novel agents for use in IHD
Ivabradine (funny current blocker, decrease HR and myocardial oxygen consumption) Ranolazine (reduce Ca overload, anti-arrhythmic) Trimetazidine (Increase energy for myocardial contraction) Nicorandil (dilation of coronary resistance arterioles and vasodilation)
43
Side effects of Ivabradine
Phosphenes (seeing ring of light) Bradycardia and AFib Headache, dizziness Ventricular extrasystoles, 1st degree heart block
44
Side effects of Ranolazine
Long QT headache, dizziness, syncope, postural hypotension nausea, constipation C/O liver or renal failure
45
Side effects of Trimetazidine
Nausea vomiting fatigue dizziness myalgia Induce Parkinsonism symptoms
46
Side effects of Nicorandil
1. c/o corticosteroids - GI perforation | 2. c/o sulphonylureas - antagonizing effect
47
Explain INOCA and first line treatment
Microvascular dysfunction > angina and ischemia without occlusion INOCA = Ischemia with no-obstructive CAD First line: Antiplatelet, anti-ischemic, nitrates
48
Characterize Prizmetal angina
Vasospastic disease - Focal/ transient vasospasm > Prinzmetal angina Cyclical Occurs at rest Common after cold exposure Risk of Ventricular arrhythmia